Provided by Tiger Trade Technology Pte. Ltd.

Johnson & Johnson

256.48
-1.9700-0.76%
Post-market: 256.640.1600+0.06%16:36 EDT
Volume:6.05M
Turnover:1.54B
Market Cap:617.94B
PE:29.70
High:257.80
Open:256.22
Low:251.95
Close:258.45
52wk High:281.07
52wk Low:184.66
Shares:2.41B
Float Shares:2.40B
Volume Ratio:0.75
T/O Rate:0.25%
Dividend:5.24
Dividend Rate:2.04%
EPS(TTM):8.64
EPS(LYR):11.03
ROE:25.74%
ROA:8.59%
PB:7.27
PE(LYR):23.25

Loading ...

Top Johnson & Johnson Executive Makes Major Stock Move

TIPRANKS
·
Sep 05

Estee Lauder Cos. Cl a Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 05

Wuhan Dazhong Dental Proposes Wang Hong as Executive Director to Replace Guo Jiaping

Reuters
·
Sep 04

J&J EVP, Worldwide Chair MedTech Timothy Schmid Disposes of 33,597 Common Shares Worth $9.23 Million

Reuters
·
Sep 04

Perrigo Co. PLC Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 04

Estee Lauder Cos. Cl a Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Sep 03

Johnson & Johnson to Present at Deutsche Bank 2026 Healthcare Summit

Reuters
·
Sep 03

Sector Update: Healthcare

MT Newswires Live
·
Sep 03

Johnson & Johnson's Drug Pipeline Supports Growth Outlook, UBS Securities Says

MT Newswires Live
·
Sep 02

LIVE Markets-Wall Street Starts Slow, Dow Leads

Reuters
·
Sep 02

Johnson & Johnson Stock (JNJ) Opened Up by 3.15% on Sep 2: Key Drivers Unveiled

TradingKey
·
Sep 02

Johnson & Johnson, Boeing Share Gains Contribute to Dow's 250-Point Climb

Dow Jones
·
Sep 02

Movement Alert|Johnson & Johnson Rises 3.05% in Regular Trading, UBS Significantly Raises Price Target to $320

Market Focus
·
Sep 02

UBS Raises Price Target on Johnson & Johnson to $320 From $280, Keeps Buy Rating

MT Newswires Live
·
Sep 02

Johnson & Johnson assumed with a Buy at UBS

TIPRANKS
·
Sep 02

Johnson & Johnson : UBS Raises Target Price to $320 from $280

THOMSON REUTERS
·
Sep 02

Johnson & Johnson EVP Thomas Cavanaugh Files Initial Beneficial Ownership Statement

Reuters
·
Sep 02

Estee Lauder Cos. Cl a Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 02

Johnson & Johnson (JNJ) Stock May Trade At A Discount As Europe Backs Tecvayli

Simply Wall St.
·
Sep 01

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Sep 01